Ausgabe 9/1998
Inhalt (15 Artikel)
Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma
V. Toscano
Polycystic ovary syndrome — loss of the apoptotic mechanism in the ovarian follicles?
Roy Homburg, A. Amsterdam
Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset
Lourdes Ibáñez, F. de Zegher, N. Potau
The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies
Randall B. Barnes
Adrenal hyperandrogenism in the pathophysiology of polycystic ovary syndrome
Enrico Carmina, R. A. Lobo
Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
Jan Holte
Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome
Janet E. Hall, A. E. Taylor, F. J. Hayes, W. F. Crowley Jr.
How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism
Dan Apter
Estrogen — Progestagen therapy in the management of the polycystic ovary syndrome
John C. Marshall
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Evanthia Diamanti-Kandarakis
The feasibility of long-term treatment of polycystic ovary syndrome with GnRH-agonists
Sarah L. Berga
Attenuation of hyperinsulinemia in polycystic ovary syndrome: What are the options?
David A. Ehrmann
How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?
C. Cortet-Rudelli, Didier Dewailly
New routes in the polycystic ovary syndrome labyrinth: A way out?
Paolo Moghetti, R. Castello